Screen shot 2017 07 13 at 2.18.11 pm
Rnagri 20logo.jpg 20large


Manufacture costs of RNA for RNAi topical applications in agriculture are prohibitive. RNAgri technology will reduce costs to allow commercial feasibility.

  • Stage Product In Development
  • Industry Agriculture
  • Location St Louis, MO, US
  • Currency USD
  • Founded February 2011
  • Employees 3
  • Incorporation Type C-corp
  • Website

Company Summary

RNAgri technology addresses a key impediment to broad acre use of topical RNAi products, RNA production costs. Industrial scale low cost production is now feasible at less than $1.00 per gram. Delivery options are in development. We use molecular biology, microbiology and chemical engineering to produce high purity low cost RNA sequences. We have a strong and growing intellectual property position as well as solid freedom to operate.


  • Business and Technology background. Twenty five years with Monsanto, five as President of Monsanto China. Arysta LifeScience Global Marketing and Supply Chain Lead. AMVAC Director Technology, AMVAC BOD since 2008 and Lead Director last three years. In China formed biotech joint ventures and served on their boards. Monsanto leader in technology and global product management. Stewarded product differentiation for Roundup patent expiration.